Korea United Pharm Inc
KRX:033270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Saudi Arabian Mining Company SJSC
SAU:1211
|
SA |
|
As One Corp
TSE:7476
|
JP |
|
Polyrocks Chemical Co Ltd
SSE:688669
|
CN |
|
O
|
Olvi Oyj
SWB:OVI
|
FI |
|
Nasmed Ozel Saglik Hizmetleri Ticaret AS
IST:EGEPO.E
|
TR |
|
V
|
VRL Logistics Ltd
BSE:539118
|
IN |
|
P
|
Pricol Ltd
NSE:PRICOLLTD
|
IN |
|
Axiata Group Bhd
KLSE:AXIATA
|
MY |
Korea United Pharm Inc
Total Receivables
Korea United Pharm Inc
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Korea United Pharm Inc
KRX:033270
|
Total Receivables
₩57.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Yuhan Corp
KRX:000100
|
Total Receivables
₩714.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Receivables
₩242.2B
|
CAGR 3-Years
53%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Receivables
₩341.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-8%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Receivables
₩55.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Total Receivables
₩30.3B
|
CAGR 3-Years
58%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Korea United Pharm Inc
Glance View
KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong and currently employs 885 full-time employees. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Korea United Pharm Inc's Total Receivables?
Total Receivables
57.2B
KRW
Based on the financial report for Sep 30, 2025, Korea United Pharm Inc's Total Receivables amounts to 57.2B KRW.
What is Korea United Pharm Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
2%
Over the last year, the Total Receivables growth was 19%. The average annual Total Receivables growth rates for Korea United Pharm Inc have been 7% over the past three years , 5% over the past five years , and 2% over the past ten years .
